The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, Travere Therapeutics Inc’s stock clocked out at $21.09, up 0.72% from its previous closing price of $20.94. In other words, the price has increased by $0.72 from its previous closing price. On the day, 1.74 million shares were traded. TVTX stock price reached its highest trading level at $21.34 during the session, while it also had its lowest trading level at $20.5511.
Ratios:
To gain a deeper understanding of TVTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.03 and its Current Ratio is at 2.05. In the meantime, Its Debt-to-Equity ratio is 12.20 whereas as Long-Term Debt/Eq ratio is at 9.94.
On October 21, 2024, Wells Fargo Upgraded its rating to Overweight which previously was Equal Weight and also upped its target price recommendation from $9 to $27.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 05 ’25 when Cline Christopher R. sold 1,784 shares for $21.05 per share. The transaction valued at 37,553 led to the insider holds 93,126 shares of the business.
Dube Eric M sold 18,924 shares of TVTX for $398,350 on May 05 ’25. The CHIEF EXECUTIVE OFFICER now owns 419,173 shares after completing the transaction at $21.05 per share. On May 05 ’25, another insider, Heerma Peter, who serves as the CHIEF COMMERCIAL OFFICER of the company, sold 1,771 shares for $21.05 each. As a result, the insider received 37,280 and left with 128,215 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TVTX now has a Market Capitalization of 1872893184 and an Enterprise Value of 1951114624. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.85 while its Price-to-Book (P/B) ratio in mrq is 57.05. Its current Enterprise Value per Revenue stands at 7.133 whereas that against EBITDA is -10.924.
Stock Price History:
The Beta on a monthly basis for TVTX is 0.87, which has changed by 2.1524663 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, TVTX has reached a high of $25.29, while it has fallen to a 52-week low of $6.01. The 50-Day Moving Average of the stock is 14.17%, while the 200-Day Moving Average is calculated to be 24.52%.
Shares Statistics:
It appears that TVTX traded 1.74M shares on average per day over the past three months and 1771820 shares per day over the past ten days. A total of 88.79M shares are outstanding, with a floating share count of 86.26M. Insiders hold about 2.87% of the company’s shares, while institutions hold 107.19% stake in the company. Shares short for TVTX as of 1745971200 were 10637755 with a Short Ratio of 6.13, compared to 1743379200 on 11556812. Therefore, it implies a Short% of Shares Outstanding of 10637755 and a Short% of Float of 12.060001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
